Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Save the date: Epiroc to host Capital Markets Day on December 1

Stockholm, Sweden: Epiroc, a leading productivity and sustainability partner for the mining and infrastructure industries, will host an online Capital Markets Day for institutional investors, analysts and financial media on December 1, 2021, at 15:00 CET.The purpose of the 2.5-hour event is to give an update on Epiroc’s strategy for profitable growth. Topics such as innovation, aftermarket, operational excellence and sustainability will be covered. Participating from Epiroc will be Helena Hedblom, President and CEO; Anders Lindén, CFO; and other managers. Instructions on how to register

Annual Report 2020: Scandion Oncology is setting the pace for the future

Scandion Oncology’s Annual Report 2020 has now been published and is available on the company’s website (www.scandiononcology.com ).Bo Rode Hansen, President & CEO, Scandion Oncology A/S comments: “In 2020, we met major catalysts with initiation of clinical trials, securing financing, preparing for list change to Nasdaq and internationalization. We saw the first signs of activity with SCO-101 and FOLFIRI in patients. This enabled the company to secure a strong financial position and start building the organization for the future.  In

Nightingale Health signed service agreement for health and well-being services in Japan

Company release Inside information 29 April 2021 at 9:15 a.m. (Finnish time) Nightingale Health Plc, Nightingale Health Japan KK, a fully owned subsidiary of Nightingale Health Plc (together “Nightingale”), and Welltus Inc., a fully owned subsidiary of Mitsui & Co. Ltd have entered into a service agreement to sell health and well-being services in the Japanese market. With the agreement, Mitsui will start selling services that utilize Nightingale’s blood analysis technology, via its subsidiary Welltus. Welltus is building its wellness and prevention platform in the Japanese

Annual Report 2020

SGL TransGroup International A/S (SGL Group) has today published the annual report 2020 SGLT Holding (SGLT Holding I LP) · For SGLT Holding, the 2020 revenue was USD 1.2 billion and Adjusted EBITDA excluding the impact of IFRS 16 leases was USD 50.4 million; compared to 2019 organic growth of 8% in revenue and 17% increase in Adjusted EBITDA despite disruptions from COVID-19 · The strong performance was derived through the strength of our entrepreneurial business model and the breadth and diversity of our customers and partners, combined with disciplined execution of COVID-19

Eficode wins two global Atlassian Partner of the Year awards 2020: in DevOps and in Services

Eficode has now earned the award in DevOps for three consecutive years Helsinki, April 28, 2021 - Atlassian today named Eficode, the leading DevOps company in Europe, the Atlassian Partner of the Year 2020: DevOps. Simultaneously Atlassian named Riada - Now part of Eficode, Atlassian Partner of the Year 2020: Services. In 2020, Eficode and Riada have continued to grow Atlassian services’ adoption, both as managed services, and through professional services. They also achieved major customer milestones with Jira Align and Jira Service Management. Throughout 2020 they helped a

Read original

SpareBank 1 SR-Bank ASA: Annual General Meeting held

The Annual General Meeting of SpareBank 1 SR-Bank ASA was held on 28 April 2021. Meeting was held digitally due to COVID-19. All items on the agenda were adopted as proposed, cf. the notice published on 7 April 2021. The minutes of the Annual General Meeting is enclosed. The information is subject to the disclosure requirements set out in section 5-12 of the Norwegian Securities Trading Act. Contact:Inge Reinertsen, CFO, Tel. +47 909 95 033

Axolot Solutions Holding AB (publ) - Interim report January-March 2021

The operations are in all aspects preparing in order to be well positioned as the society opens up again after the pandemic.Summary of the first quarter 2021 Financially · Net sales amounted to 483 tSEK (725 tSEK for the corresponding quarter in 2020), which in principal refers to trial runs.  · Other revenues were 190 tSEK (446), which relates to state subsidies and support.  · Earnings before interest and tax became -4 445 tSEK (-6 237), where the result improvement relates to restructuring measures taken one year ago, due to the pandemic.  · Net earnings per share

Q1 2021 Trading Update and board change

This announcement contains inside information International Personal Finance Q1 2021 trading update and board change 29 April 2021 International Personal Finance plc specialises in providing unsecured consumer credit to 1.7 million customers across 11 markets.  We operate the world's largest home credit business and a successful fintech business. Highlights · Robust Q1 trading performance delivered as we rebuild the business · Good progress in credit issued with YoY contraction moderating to 18% in Q1 2021 compared to 31% in Q4 2020  · Continued strong

Nel ASA: Invitation to presentation of Q1 2021 results

(Oslo, 29 April 2021) Nel ASA (Nel) will announce its first quarter 2021 report on Tuesday 4 May at 07:00 CET and will host a virtual presentation at 08:00 CET. Due to Covid-19 restrictions, physical participation at the results presentation will not be possible. The presentation will be held in English. The presentation will be broadcasted live at www.nelhydrogen.com and can also be streamed at https://channel.royalcast.com/landingpage/hegnarmedia/20210504_1/. The presentation will be followed by Q&A based on submitted questions during the call. The report and presentation will be

Inzile AB (publ) Interim Report 1 January – 31 Mars 2021

First quarter 2021 in brief · Establishment of a sales company in Norway launches international expansion · Evaluation of production in Spain initiated · Private placement provided the company with MSEK 127 First quarter 2021 in numbers · Net sales amounted to MSEK 1,1 (0) · Operating profit (EBIT) amounted to MSEK -19,3 (-10.1) · The result for the period amounted to MSEK -19,4 (-10.1) · Earnings per share before and after dilution amounted to SEK -1,01 (-0.81) Events during the period Inzile has launched its international expansion by establishing a sales

Interim Report – 3 months 1 January-31 March 2021

· Revenue amounted to MSEK 2,325 (1,539), with the change compared with the previous year primarily attributable to the acquisition of Swedol. Compared with revenue for the corresponding quarter in the preceding year including Swedol (MSEK 2,368), revenue declined by 2 percent.* · EBITA amounted to MSEK 125 (91), corresponding to an EBITA margin of 5.4 percent (5.9). The change compared with the previous year is primarily attributable to the acquisition of Swedol. Compared with EBITA for the corresponding period in the previous year including Swedol (MSEK 134), EBITA declined by 7

Electrolux Professional´s SkyLine oven supports unique safeguarding in the handling of Covid-19 test samples

In cooperation with the UK life science company BiologIC Technologies and Astra Zeneca Cambridge COVID-19 Test center, Electrolux Professional´s award winning SkyLine combi oven will be used to support a high-throughput solution for heat inactivation of COVID-19 patient samples."With the advanced technology of the SkyLine combi oven, we support yet another milestone in fighting the pandemic that is affecting people and businesses around the world. We are very proud to play a role in safeguarding the process of handling the COVID-19 samples, to protect all people involved in testing”, says

Neste's Interim Report for January-March 2021

Neste Corporation, Interim Report, 29 April 2021 at 9 a.m. (EET) Resilient Renewable Products business – challenging market in Oil Products continued First quarter in brief: · Comparable operating profit totaled EUR 302 million (EUR 408 million) · Operating profit totaled EUR 458 million (EUR 197 million) · Renewable Products' comparable sales margin was USD 699/ton (USD 685/ton) · Oil Products' total refining margin was USD 6.73/bbl (USD 11.03/bbl) · Cash flow before financing activities was EUR -645 million (EUR -120 million) · Return on average capital employed (

Nordnet AB (publ) – interim report January-March 2021

Nordnet today publishes its interim report for the first quarter 2021. The full report is available at www.nordnetab.com- The first quarter of the year was an eventful and successful period for Nordnet. During the first three months of the year, 167,200 new savers joined Nordnet – a figure almost 90 percent higher than for the first quarter of 2020, and more than for the whole of 2019. All our markets show double-digit percentage increases in the customer base on an annual basis, and Denmark and Norway are in what virtually can be described as hyper-growth in terms of new customers. The

Midsona - Interim Report January-March 2021

A quarter of continued growth and good profitabilityJanuary-March 2021 (first quarter) · Net sales amounted to SEK 965 million (946), but with challenges in organic growth as a result of the previous year’s hoarding effects. · EBITDA amounted to SEK 94 million (107) before items affecting comparability, corresponding to a margin of 9.7 percent (11.3). · Profit for the period was SEK 33 million (47), corresponding to earnings per share of SEK 0.50 (0.72) before and after dilution. · Free cash flow amounted to SEK -26 million (2). · The brand Kung Markatta was named Sweden's

Orexo Q1 2021 Interim Report

Investing in future growth driversQ1 2021 summary · Total net revenues of SEK 132.3 m (175.0) · Net earnings of SEK -31.5 m (82.6) · EBITDA of SEK -23.9 m (39.1) · US Pharma segment (ZUBSOLV® US) net revenues of SEK 126.8 m (163.9), EBIT of SEK 66.1 m (75.9) · Cash flow from operating activities of SEK -47.8 m (48.1), cash balance of SEK 725.5 m (861.4) · A new patent for OX124, overdose rescue medication, was issued by the US Patent and Trademark Office (USPTO), protecting the technology until 2039 · Issued a new corporate bond amounting to a nominal value of SEK

Interim report 1 January – 31 March 2021

First quarter 2021  ·Order intake increased by 6% to SEK 5,747 million (5,401). For comparableunits, it was an increase of 5%. · Net sales increased by 3% to SEK 5,147 million (4,976). For comparableunits, it was an increase of 3%. · EBITA increased by 16% to SEK 713 million (616), corresponding to an EBITAmargin of 13.9% (12.4%). · Profit for the quarter increased by 19% to SEK 461 million (388), andearnings per share were SEK 1.27 (1.07). · Cash flow from operating activities increased by 16% and amounted to SEK489 million (421).  CEO’s message

Pexip Holding ASA: Notice of Annual General Meeting on May 20, 2021

The annual general meeting of Pexip Holding ASA (OSE: PEXIP) will be held on May 20, 2021 at 16:30 (CEST). Due to the Covid-19 situation, the annual general meeting will be held as a digital meeting with electronic voting. Please refer to the attached guide for online participation. It is possible to vote in advance or attend the meeting by proxy. Please see further detailed information in the notice of the annual general meeting. The full notice, agenda and appendices are attached hereto. Further information is also to be found on https://investor.pexip.com/corporate-governance/annual-

Olvi Group’s Interim Report, 1 January to 31 March 2021 (3 Months)

OLVI PLC                Interim Report 29 April 2021 at 9:00 am Olvi Group’s Interim Report, 1 January to 31 March 2021 (3 Months) Interim Report in brief Olvi Group’s first-quarter sales volume, net sales and operating profit increased on the previous year. Easter sales fell into the first quarter and exports increased; this boosted the Group’s overall development. The Group’s financial standing remained on a good level. Near-term outlook Olvi’s operating profit for fiscal year 2021 is expected to remain on the previous year’s good level. Second-quarter earnings development

During the first quarter of 2021, YIT began the construction of three apartment buildings in Russia

YIT Corporation Investor News April 29, 2021, at 09:00 a.m.In January–March 2021, YIT started the construction of three new apartment buildings in Russia. The properties are located in St. Petersburg and the Moscow region, and their combined value is approximately EUR 38 million. The buildings will consist of nearly 550 apartments in total. The residential start-ups are booked in the order book of the first quarter of 2021. In St. Petersburg, YIT started the construction of an apartment building called Wellamo. The 10-storey building will consist of almost 100 apartments, approximately

Upcoming changes in Tele2’s Group Leadership Team

Stockholm – Tele2 AB (“Tele2”) (Nasdaq Stockholm: TEL2 A and TEL2 B) today announced that Mikael Larsson, Executive Vice President Group CFO, and Samuel Skott, Executive Vice President Chief Commercial Officer, will both leave the company on 1 September 2021.Mikael Larsson joined Tele2 in 2018 as former CFO of Com Hem. He has played an instrumental part in the successful merger and in the following transformation of Tele2, including the international consolidation and the steps towards 5G, Remote PHY and fixed-mobile convergence. Mikael has been CFO for listed companies during the last

ChloraSolv is approved for leg ulcers – doubles the potential market size in Europe

RLS Global, whose ambition is to be a leading research-driven platform company for wounds, has received regulatory approval that ChloraSolv can also be used for leg ulcers. This increases the potential market size by 100 percent. ChloraSolv has been approved for diabetic foot ulcers since 2019, where now leg ulcers also are included.ChloraSolv is a gel with antimicrobial properties that is used in cleansing wounds, so-called debridement. Without damaging the healthy tissue, ChloraSolv softens the dead tissue that prevents the wound from healing. The dead tissue can then be removed more

There are no items matching the current filter
There are no more items matching the current filter
Back to top